期刊文献+

补肾疏肝方药治疗肝肾阴虚型帕金森病伴发轻中度抑郁障碍 被引量:22

Clinical Trial of Bushen Shugan Decoction on Mild to Moderate Level of Depression in Parkinson Disease with Liver and Kidney Yin Deficiency
原文传递
导出
摘要 目的:观察补肾疏肝方药治疗肝肾阴虚型帕金森病伴发轻中度抑郁障碍的临床疗效。方法:将109例肝肾阴虚型帕金森病伴发轻中度抑郁障碍患者随机分为治疗组和对照组。对照组根据国际帕金森病治疗指南用药原则进行治疗,治疗组在此基础上加用补肾疏肝方药,连续服用9个月,试验终点时间为9个月。在治疗前、入组后每隔3个月及试验终点时间分别对帕金森病统一评分量表(UPDRS)、Hamilton抑郁量表(HAMD)、日常生活能力量表(ADL)、中医肝肾阴虚症状评分等进行比较。结果:治疗后,两组UPDRS总分及ADL评分均有升高趋势,治疗组较对照组评分上升缓慢,试验终点时,治疗组评分显著低于对照组(P<0.05或P<0.01)。治疗后,两组HAMD评分均显著下降(P<0.01),两组同期评分比较无显著差异。治疗后,治疗组中医肝肾阴虚症状评分显著下降(P<0.01),对照组评分显著上升(P<0.05或P<0.01)。试验终点时,治疗组中医肝肾阴虚症状评分显著低于对照组(P<0.01)。结论:补肾疏肝方药能有效改善肝肾阴虚型帕金森病伴发轻中度抑郁障碍患者的运动、抑郁等症状,提高日常生活能力,缓解肝肾阴虚症状。 Objective: To observe the curative effect of Bushen Shugan decoction on mild to moderate level of depression in Parkinson disease (PD)with liver and kidney yin deficiency. Method: One hundred and nine PD patients were randomly assigned to the treated group and the control group. Both were treated according to the international medication guiding principle for PD treatment, and the treated group was administered with Bushen Shugan decoction additionally. The treatment course lasted for 9 consecutive months, and the end point was the end of the 9th month. The scores of unified Parkinson's disease rating scale (UPDRS), Hamilton depression rating scale (HAMD), activities of daily living (ADL) and liver and kidney yin scale of traditional Chinese medicine (TCM) were evaluated before treatment, every 3 months of the treatment and at the end point. Result: After treatment, UPDRS total scores and ADL scores in both groups showed a significant ascending trend at a slower rate in the treated group than in the control group;At the end point, the scores in the treatment group were lower than the control group, there was a significant difference between the two groups (P〈0.05 or P〈0.01). After treatment, HAMD scores in both groups showed an descending trend in both groups, but there was no significant difference between the two groups at the same period. After treatment, the TCM scores decreased in the treatment group while increased in the control group;At the end point, the TCM scores in the treatment group were much lower than the control group, there was a significant difference between the two groups (P〈0.01). Conclusion: The recipe for Bushen Shugan decoction could improve the motor and depressive symptoms, as well as the liver and kidney yin deficiency symptoms of traditional Chinese medicine, which could enhance PD patients' activities of daily life.
出处 《中国实验方剂学杂志》 CAS 北大核心 2013年第24期324-328,共5页 Chinese Journal of Experimental Traditional Medical Formulae
基金 上海市卫生局青年科研项目(2009Y084) 上海市杏林新星计划项目(ZYSNXD011-RC-XLXX-20130011)
关键词 帕金森病 抑郁 中西医结合治疗 补肾疏肝方药 Parkinson disease depression treatment with integrated Chinese and western medicine Bushen Shugan decoction
  • 相关文献

参考文献15

  • 1Zhang Z X, Roman G C, Hong Z, et al. Parkinson' s disease in China: prevalence in Beijing, Xian, and Shanghai[ J ]. Lancet, 2005, 365 (9459) :595.
  • 2Kasten M, Kertelge L, Tadic V, et al. Depression and quality of life in monogenic compared to idiopathic, early-onset Parkinson's disease[J]. Mov Disord, 2012, 27(6) :754.
  • 3Vu T C, Nutt J G, Holford N H. Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease[J]. Br J Clin Pharmacol, 2012, 74 (2) :284.
  • 4Riedel O, Dodel R, Deusehl G, et al. Depression andcare-dependency in Parkinson's disease: results from a nationwide study of 1449 outpatients [ J ]. Parkinsonism Relat Disord, 2012, 18(5) :598.
  • 5Lindqvist D, Kaufman E, Brundin L, et al. Non-motor symptoms in patients with Parkinson's disease- correlations with inflammatory cytokines in serum [ J ]. PLoS One, 2012, 7(10):e47387.
  • 6Petrovic I N, Stefanova E, Kozic D, et al. White matter lesions and depression in patients with Parkinson's disease[J]. J NeurolSci, 2012, 322(1/2) :132.
  • 7Yang S, Sajatovic M, Walter B L. Psychosocial interventions for depression and anxiety in Parkinson's disease [ J ]. J Geriatr Psychiatry Neurol, 2012, 25 ( 2 ) : 113.
  • 8Costa F H, Rosso A L, Maultasch H, et al. Depression in Parkinson's disease : diagnosis and treatment[ J ]. Arq Neuropsiquiatr, 2012, 70 ( 8 ) : 617.
  • 9Schwarz J, Odin P, Buhmann C, et al. Depression in Parkinson's disease [ J ]. J Neurol, 2011, 258 ( Suppl 2 ) : $336.
  • 10Olanow C W, Watts R L, Koller W C. An algorithm (decision tree ) for the management of Parkinson' s disease ( 2001 ) : treatment guidelines [ J ]. Neurology, 2001, 56(11 Suppl 5) :S1.

二级参考文献13

  • 1刘军,陈生弟,刘振国,乐卫东.大鼠纹状体区多巴胺受体的变化对动物行为的影响[J].上海第二医科大学学报,2004,24(7):531-533. 被引量:2
  • 2徐琲琲,刘纯青,马涛,周晓棉,曹颖林,张万琴.人参皂苷Re对MPTP致帕金森病模型小鼠多巴胺能神经元的保护作用[J].沈阳药科大学学报,2005,22(1):36-44. 被引量:26
  • 3李仪奎.中药药理试验方法学[M].上海:上海科技出版社,1991,298-353.
  • 4Kawai H, Makino Y, Hirobe M, et al. Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives:uptake by dopamine transporter and activity to induce parkinsonism. J Neurochem, 1998,70(2) :745.
  • 5Storch A,Hwang YI,Gearhart DA,et al.Dopamine transporter- mediated cytotoxicity of β-carbolinium derivatives related to Parkinson's disease :relationship to transporter -dependent uptake. J Neurochem,2004,89(3):685.
  • 6Nikam S,Nikam P,Ahaley SK,et al.Oxidative stress in Parkinson's disease.India J Clin Biochem, 2009,24 ( 1 ) : 98.
  • 7Bezard E, Ravenscroft P, Gross CE, et al. Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-Methyl-4-phen- yl-1,2, 3,6-tetrahydropyridine monkeys [ J ]. Neurobiol Dis, 2001, 8(2): 343 - 350.
  • 8Ariano MA, Grissell AE, Littlejohn FC, et al. Partial dopamine loss enhances activated caspase-3 activity: Dif- ferential outcomes in striatal projection systems [J]. J Neurosci Res, 2005, 83(3): 387-396.
  • 9Olanow CW, Obeso JA, Stocchi F. Continuous dopa- mine-receptor treatment of Parkinson's disease: Scientific rationale and clinical implications [J].Lancet Neurol, 2006, 5(8): 677-687.
  • 10赵虹,李文伟,高俊鹏,周子懿,吕磊,汪涛,顾喜喜,范越,陆振宇,唐宇平,周洋,蔡定芳.补肾养肝方药治疗肝肾阴虚型帕金森病临床研究[J].中国中西医结合杂志,2007,27(9):780-784. 被引量:40

共引文献25

同被引文献289

引证文献22

二级引证文献183

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部